Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,559 | 4,798 | 8,150 | 14,066 | 20,517 |
| TOTAL | $1,671 | $4,971 | $8,445 | $14,416 | $20,824 |
| Non-Current Assets | |||||
| PPE Net | 6,834 | 7,513 | 8,107 | 8,694 | 9,085 |
| Intangibles | 317 | 325 | 334 | 342 | 350 |
| Other Non-Current Assets | 3 | 15 | 14 | 43 | 4 |
| TOTAL | $7,153 | $7,852 | $8,455 | $9,079 | $9,439 |
| Total Assets | $8,824 | $12,823 | $16,900 | $23,495 | $30,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 95 | 95 |
| Accounts payable and accrued liabilities | 1,281 | 1,096 | 391 | 272 | 232 |
| Accrued Expenses | 26 | 263 | 144 | 46 | 24 |
| TOTAL | $1,307 | $1,359 | $534 | $413 | $351 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 1,500 | 0 | 0 |
| TOTAL | $N/A | $N/A | $1,500 | $N/A | $N/A |
| Total Liabilities | $1,307 | $1,359 | $2,034 | $413 | $351 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,431 | 14,677 | 11,746 | 11,592 | 11,515 |
| Common Shares | 0 | 0 | 0 | 0 | 12 |
| Retained earnings | -148,842 | -139,375 | -131,081 | -122,492 | -114,385 |
| TOTAL | $7,518 | $11,464 | $14,866 | $23,082 | $29,911 |
| Total Liabilities And Equity | $8,824 | $12,823 | $16,900 | $23,495 | $30,262 |